Two Different Paths To Upside
Our two trades today come from different parts of our research process. The first is the highest-ranked name on our current Top Names list, which estimates the stocks with the highest potential six-month returns. The second comes from our Multibaggers list, our tracked group of outside analysts with multiple recent winners of 100% or more. One business sells software into complex supply chains; the other is developing genetic medicines.
The software company reported stronger cloud demand in its latest quarter. Its shares closed Thursday above a rising 50-day exponential moving average, and its momentum sits in the middle of our preferred RSI range. The biotech has a longer and less certain path: its clinical plans include potential 2027 milestones, while financing and execution risks keep this a speculative catalyst trade.
The options markets for both names are wide. We’re setting a maximum opening debit for each complete position. Paid subscribers will find the names, exact orders, model values, maximum risks and exit plans below.
New to our trade alerts? Start Here explains how we select trades, size their maximum risk and manage the exits.
Today’s Top Names Trade
Theme: Cloud software for supply chains and commerce.
RSI: 53; Chartmill Technical Rating: 8; Setup Rating: 9; Fundamental Rating: 7.
